Clinical Development Clinical Research Pharmaceutical Companies Treatment 
Drug Discovery World
MARCH 5, 2024
In her day-to-day role, she is responsible for the development of UCB’s epilepsy discovery strategy, working with researchers to advance understanding of epilepsies while ensuring candidates for a future clinical treatment pipeline to improve the lives of those living with the condition.
Drug Target Review
SEPTEMBER 5, 2024
I am a pharmacist by training and continued with a PhD in Clinical Pharmacology. However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
DECEMBER 22, 2022
Examples of these changes include refining sample size, abandoning treatments or doses, or stopping the trial early if success or lack of efficacy is clear. Shelley McLendon has more than 25 years of clinical research experience, 19 of which are tenured at ICON. About the author .
The Pharma Data
JANUARY 6, 2021
7, 2021 /PRNewswire/ — UNION therapeutics A/S ( UNION ) today announces that the US Food and Drug Administration (FDA) has approved an Investigational New Drug program (IND) for oral orismilast; a next generation PDE4-inhibitor for the treatment of plaque psoriasis in adults. One step closer to a novel treatment.
The Pharma Data
JANUARY 14, 2021
We are strongly encouraged by these data and the potential for a frontline targeted treatment that can improve overall survival,” said Zev A. Associate Professor of Medicine at UCLA, Co-director of the Gastrointestinal Oncology Program and Director of Early Phase Clinical Research at the Jonsson Comprehensive Cancer Center.
Drug Discovery World
OCTOBER 16, 2023
Indeed, this is bolstered by top tier universities like Newcastle University, which specialises in structure-based approaches for drug discovery, developing innovative technologies that support the identification of new medicines, and is well-established in cancer drug discovery.
The Pharma Data
OCTOBER 19, 2020
an emerging leader focused on the treatment of kidney disease, sepsis and organ injury, today announced the appointment of Maarten Kraan, M.D., They both bring extensive experience from big pharma and biotechnology companies to execute on the plan to prepare for BLA and commercial readiness. 20, 2020 09:00 UTC. pharma.com.
Expert insights. Personalized for you.
147 
Let's personalize your content